XML 114 R103.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Incentive Plans - Stock Option Activity (Details)
$ / shares in Units, $ in Thousands
 6 Months Ended 9 Months Ended
Dec. 31, 2022
$ / shares
shares
Mar. 31, 2023
USD ($)
$ / shares
shares
Number of Options    
Beginning balance (in shares) | shares 19,310,706 19,310,706
Granted (in shares) | shares   1,991,427
Exercised (in shares) | shares   (726,425)
Forfeited, expired or cancelled (in shares) | shares   (993,984)
Ending balance (in shares) | shares   19,581,724
Vested and exercisable (in shares) | shares   14,385,171
Vested and exercisable, and expected to vest thereafter (in shares) | shares   19,341,889
Weighted Average Exercise Price    
Beginning balance (in USD per share) | $ / shares $ 15.22 $ 15.22
Granted (in USD per share) | $ / shares   19.10
Exercised (in USD per share) | $ / shares   4.39
Forfeited, expired or cancelled (in USD per share) | $ / shares   37.14
Ending balance (in USD per share) | $ / shares   14.92
Vested and exercisable (in USD per share) | $ / shares   10.14
Vested and exercisable, and expected to vest thereafter (in USD per share) | $ / shares   $ 14.66
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Weighted Average Remaining Contractual Term 6 years 11 months 8 days 6 years 3 months 7 days
Weighted Average Remaining Contractual Term, Vested and exercisable   5 years 7 months 9 days
Weighted Average Remaining Contractual Term, Vested and exercisable, and expected to vest   6 years 3 months
Aggregate Intrinsic Value, Vested and exercisable | $   $ 62,657
Aggregate Intrinsic Value, Vested and exercisable, and expected to vest | $   $ 64,261